LENZ Therapeutics, Inc. (LENZ) stock
LENZNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 9/3055% below fair value
$3.50−0.32 (-8.38%)
Close on Nov 17, 2026Market cap $109.97MP/E –Yield –
LENZ Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
LENZ Therapeutics's market cap was $129.12M on Nov 11, 2026, against $872.51M a year earlier. Over the last 5 years it ranged from $30.18M to $1.33B, with a median of $130.94M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $129.12M | -71.8% |
| 2025 | Dec 31, 2025 | $457.41M | -42.3% |
| 2024 | Dec 31, 2024 | $793.37M | +2064.0% |
| 2023 | Dec 29, 2023 | $36.66M | -21.3% |
| 2022 | Dec 30, 2022 | $46.60M | -73.3% |
| 2021 | Dec 31, 2021 | $174.25M | – |
See a number that looks wrong?